Diabetes Insights - Breakthroughs and Innovators

In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on continuous glucose monitoring (CGM) in people living with type 2 diabetes.

As CGM becomes increasingly available, clinicians, researchers, and policymakers are seeking clear evidence-based guidance on its role in diabetes management. The discussion explores why CGM was selected as a priority topic, how guideline questions are developed, the importance of patient involvement, and the rigorous process used to evaluate clinical evidence.

The conversation also highlights the broader outcomes that matter to people living with diabetes (including quality of life, confidence and behaviour change) and examines how future recommendations could influence healthcare policy and access to diabetes technology across Europe and beyond.

In this episode, Prof. Eberhard Standl marks an extraordinary milestone - 50 years since attending his first EASD Congress. Looking back on a career spanning five decades, he shares how diabetes care has evolved from the challenges of diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, immunotherapies, and the potential reversal of type 2 diabetes.

Prof. Standl discusses the enduring importance of lifestyle interventions, the value of long-term partnerships between clinicians and people living with diabetes, and emerging research linking diabetes, obesity, metabolism, and cancer. He also reflects on the collaborative spirit of the diabetes research community and the exciting possibilities that lie ahead for both type 1 and type 2 diabetes.

In this episode, Prof. Richard Holt and Prof. Kirsten Nørgaard discuss the updated EASD-ADA Consensus Report on Type 1 Diabetes, a comprehensive update designed to provide timely, evidence-based guidance for healthcare professionals managing type 1 diabetes.

They explain how consensus reports differ from formal clinical guidelines, why they remain an important tool for advancing diabetes care, and how the latest update reflects major developments in diabetes technology and clinical practice since the original report was published in 2021.

The conversation explores stronger recommendations for continuous glucose monitoring (CGM) and automated insulin delivery systems, as well as new sections covering obesity management, diabetes-related complications, and cardiovascular risk factors. The speakers also discuss how consensus reports can influence healthcare policy, improve access to diabetes technologies, and support more consistent standards of care worldwide.

With the report currently open for public consultation, they highlight why feedback from the diabetes community is essential to shaping the final document and ensuring its relevance across diverse healthcare settings.

In this episode, Prof. Partha Kar joins EASD TV Host, Vivienne Parry, to explore the growing role of social media in healthcare and diabetes care.

From combating misinformation and amplifying patient voices to navigating online abuse and professional risks, Prof. Kar shares why he believes clinicians should engage - not retreat - from digital platforms. He discusses how social media helped shape conversations around continuous glucose monitoring (CGM) access in the UK, why visibility and accountability matter in healthcare leadership and how platforms like X, LinkedIn and Substack are changing the way research and medical information are shared.

The conversation also explores implementation science, global inequities in diabetes care and why translating research into real-world impact is one of healthcare’s biggest challenges.

In this episode, Prof. Steven Kahn, Editor-in-Chief of Diabetes Care, and Deputy Editor Dr John Buse discuss their powerful editorial examining how political decisions, healthcare reform, and attacks on diversity, equity, and inclusion (DEI) could impact diabetes care and biomedical research in the United States and globally.

The conversation explores concerns around cuts to NIH and CDC funding, changes to public health policy, and the implications for chronic disease research, healthcare access, and health equity. They also discuss why diversity matters in diabetes research, the importance of peer-reviewed science, and why senior leaders in medicine must continue speaking out in support of patients, researchers, and future innovation.

Read the editorial discussed in this episode: https://diabetesjournals.org/care/article/49/1/5/163166/The-Forces-Reshaping-America-s-Health-Landscape